Search by Drug Name or NDC

    NDC 55154-8713-08 Myrbetriq 50 mg/1 Details

    Myrbetriq 50 mg/1

    Myrbetriq is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cardinal Health 107, LLC. The primary component is MIRABEGRON.

    Product Information

    NDC 55154-8713
    Product ID 55154-8713_eaa551c0-5c11-45b4-9f9b-3533810c065b
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Myrbetriq
    Proprietary Name Suffix n/a
    Non-Proprietary Name mirabegron
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 50
    Active Ingredient Units mg/1
    Substance Name MIRABEGRON
    Labeler Name Cardinal Health 107, LLC
    Pharmaceutical Class Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA202611
    Listing Certified Through 2024-12-31

    Package

    NDC 55154-8713-08 (55154871308)

    NDC Package Code 55154-8713-8
    Billing NDC 55154871308
    Package 1080 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (55154-8713-8)
    Marketing Start Date 2012-06-28
    NDC Exclude Flag N
    Pricing Information N/A